This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Regulatory / Liminatus Pharma Nasdaq Delisting Notice
Regulatory delisting notice

Liminatus Pharma Nasdaq Delisting Notice

Analysis based on 8 articles · First reported May 22, 2026 · Last updated May 22, 2026

Sentiment
-70
Attention
4
Articles
8
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The delisting notice for Liminatus Pharma will likely lead to a significant drop in its stock price and liquidity, negatively impacting investors holding its shares. The potential suspension of trading on Nasdaq-100 could make it difficult for shareholders to sell their stock, reflecting poorly on the company's financial health and governance.

Biotechnology Pharmaceuticals
Event Summary

Liminatus Pharma received a delisting notice from Nasdaq-100 on May 20, 2026, for failing to comply with the $50,000,000 market value of listed securities (MVLS) and $15,000,000 market value of publicly held shares (MVPHS) requirements. This follows previous notices issued on November 19, 2025, which gave the company 180 days to regain compliance. Unless Liminatus Pharma successfully appeals the decision by May 27, 2026, trading of its common stock and warrants will be suspended on May 29, 2026. The company, led by CEO Chris Kim, intends to appeal the determination, which would stay the delisting action pending a hearing.

Entities Involved
priv
Liminatus Pharma
Liminatus Pharma received a delisting notice from Nasdaq-100 due to non-compliance with listing rules, which will lead to the suspension of its stock trading unless an appeal is successful. This event significantly impacts its ability to raise capital and its public market valuation.
Importance 100.0 Sentiment -90.0
per
Chris Kim
Chris Kim is the Chief Executive Officer of Liminatus Pharma and is responsible for the company's response to the delisting notice.
Importance 30.0 Sentiment -50.0
govactor
United States — United States Securities and Exchange Commission
Importance 0.0 Sentiment 0.0
index
Nasdaq-100
Importance 0.0 Sentiment 0.0
Relationships
United States — United States Securities and Exchange Commission related ↔ Nasdaq-100
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.